Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · IEX Real-Time Price · USD
46.96
+0.57 (1.23%)
At close: Jul 19, 2024, 4:00 PM
46.97
+0.01 (0.02%)
Pre-market: Jul 22, 2024, 7:12 AM EDT
Soleno Therapeutics Market Cap
Soleno Therapeutics has a market cap or net worth of $1.71 billion as of July 22, 2024. Its market cap has increased by 4,676.19% in one year.
Market Cap
1.71B
Enterprise Value
1.56B
1-Year Change
4,676.19%
Ranking
Category
Stock Price
$46.96
Market Cap Chart
Since November 13, 2014, Soleno Therapeutics's market cap has increased from $24.70M to $1.71B, an increase of 6,822.57%. That is a compound annual growth rate of 54.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 1.57B | 27.81% |
| Dec 29, 2023 | 1.23B | 7,477.78% |
| Dec 30, 2022 | 16.20M | -50.46% |
| Dec 31, 2021 | 32.70M | -78.72% |
| Dec 31, 2020 | 153.70M | 17.06% |
| Dec 31, 2019 | 131.30M | 257.77% |
| Dec 31, 2018 | 36.70M | 103.89% |
| Dec 29, 2017 | 18.00M | 40.63% |
| Dec 30, 2016 | 12.80M | -44.10% |
| Dec 31, 2015 | 22.90M | 126.73% |
| Dec 31, 2014 | 10.10M | -59.11% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neumora Therapeutics | 1.80B |
| Ligand Pharmaceuticals | 1.79B |
| Veracyte | 1.77B |
| Keros Therapeutics | 1.75B |
| Galapagos NV | 1.72B |
| NewAmsterdam Pharma Company | 1.70B |
| Evotec SE | 1.67B |
| Supernus Pharmaceuticals | 1.66B |